Standout Papers

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer 2002 2026 2010 2018 1.9k
  1. Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer (2006)
    Deborah K. Armstrong, Brian N. Bundy et al. New England Journal of Medicine
  2. Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis (2002)
    Robert E. Bristow, Rafael S. Tomacruz et al. Journal of Clinical Oncology
  3. Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study (2007)
    William E. Winter, G. Larry Maxwell et al. Journal of Clinical Oncology
  4. Recent progress in the diagnosis and treatment of ovarian cancer (2011)
    Danijela Jelovac, Deborah K. Armstrong CA A Cancer Journal for Clinicians
  5. Phase II Study of Bevacizumab in Patients With Platinum-Resistant Ovarian Cancer or Peritoneal Serous Cancer (2007)
    Stephen A. Cannistra, Ursula A. Matulonis et al. Journal of Clinical Oncology
  6. Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial (2017)
    Robert L. Coleman, Mark F. Brady et al. The Lancet Oncology
  7. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline (2016)
    Alexi A. Wright, Kari Bohlke et al. Journal of Clinical Oncology
  8. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline (2016)
    Alexi A. Wright, Kari Bohlke et al. Gynecologic Oncology
  9. Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline (2020)
    Panagiotis A. Konstantinopoulos, Barbara M. Norquist et al. Journal of Clinical Oncology

Immediate Impact

2 by Nobel laureates 14 from Science/Nature 78 standout
Sub-graph 1 of 16

Citing Papers

Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline
2024 Standout
Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
2022 Standout
12 intermediate papers

Works of Deborah K. Armstrong being referenced

A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors
2013
Health-Related Quality of Life During and After Intraperitoneal Versus Intravenous Chemotherapy for Optimally Debulked Ovarian Cancer: A Gynecologic Oncology Group Study
2007
and 1 more

Author Peers

Author Last Decade Papers Cites
Deborah K. Armstrong 7907 4242 4829 203 13.6k
Robert A. Burger 8870 4510 4310 200 14.4k
Gunnar B. Kristensen 7386 4200 3647 257 14.3k
Gordon Rustin 5054 5247 3348 244 15.7k
Jonathan S. Berek 7670 4038 4435 288 15.5k
William A. Cliby 6568 3376 4012 281 13.8k
Gabriella Ferrandina 5549 4763 3356 489 15.4k
Thomas J. Herzog 6011 3127 3214 326 13.0k
Maurie Markman 7701 6320 6492 412 19.5k
Pierluigi Benedetti Panici 6389 3552 3797 560 15.4k
Jeffrey M. Fowler 5834 2868 3412 185 10.4k

All Works

Loading papers...

Rankless by CCL
2026